Q1 2026 earnings snapshot

Skyward Specialty Insurance Group (SKWD) opened 2026 with Q1 revenue of US$475.9 million and basic EPS of US$1.12, supported by net income of US$49.7 million. The company reported an increase in revenue from US$328.5 million and EPS of US$1.05 in Q1 2025 to US$475.9 million and EPS of US$1.12 in Q1 2026, while trailing twelve month net income reached US$177.7 million on US$1.6 billion of revenue. With trailing net margin at 11.4% versus 10.2% a year earlier, investors are looking at a business that is converting more of each revenue dollar into profit.

See our full analysis for Skyward Specialty Insurance Group.

With the headline numbers on the table, the next step is to compare this earnings profile with the widely followed narratives around Skyward Specialty's growth potential, risk profile, and profitability momentum.

Margins and underwriting quality in focus

• On a trailing twelve month basis, Skyward Specialty generated US$177.7 million of net income on US$1.6b of revenue, for an 11.4% net margin compared with 10.2% a year ago.
• Supporters of the bullish view argue that conservative reserving and cycle-aware underwriting can sustain or lift profitability, and the margin data partly backs that up while also setting a higher bar:
  • Five year earnings growth is cited at 48.9% per year and trailing net margin is now 11.4%, which fits the bullish idea that underwriting and reserving discipline are feeding through to the bottom line.
  • At the same time, bullish expectations for margins to move toward roughly 12% or more over the next few years leave less room for error if loss ratios or reinsurance costs move against the company.

Over the last year, earnings and margin trends give supporters of the optimistic case plenty to point to, but they also highlight how much of that thesis is already being tested in current profitability. 🐂 Skyward Specialty Insurance Group Bull Case

Growth forecasts versus bearish concerns

• Earnings grew 43.2% over the last year and are forecast to rise about 15.24% per year, with revenue forecast to grow about 13% annually compared with an 11.4% benchmark for the US market's revenue growth.
• Critics in the bearish camp focus on volatility in catastrophe exposed and niche lines, and the growth numbers cut both ways against that concern:
  • The 43.2% earnings growth and 13% revenue growth forecast suggest the business has been able to expand while dealing with those risks so far.
  • However, forecast earnings growth that sits below the 16.4% US market benchmark reinforces the bearish view that volatility and higher costs could keep a lid on how fast profit grows from here.

Skeptical investors often zero in on the tension between solid reported growth and more modest forward expectations, and that contrast is central to how the cautious narrative frames risk. 🐻 Skyward Specialty Insurance Group Bear Case

Valuation gap and what needs to go right

• The stock trades at US$45.51 with a trailing P/E of 11.4x, in line with the US insurance industry average but above the cited 9x peer average, while a DCF fair value of about US$129.43 in the dataset sits much higher than the current price.
• Supportive narratives point to both the DCF fair value and a consensus analyst price target of about US$60.45, and the current results and forecasts frame what has to happen for that to play out:
  • Revenue growth of roughly 13% a year and forecast earnings growth of about 15.24% underpin the idea that earnings can compound fast enough to support a higher multiple or narrow the gap to fair value.
  • At the same time, a P/E already above the 9x peer average means any rerating case relies on the company continuing to deliver margins around 11.4% or better without the growth profile slipping below these forecasts.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Skyward Specialty Insurance Group on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

If this mix of bullish and cautious signals feels finely balanced, consider forming your own view now using the 4 key rewards.

Explore Alternatives

Skyward Specialty's current P/E above the cited peer average and earnings growth forecast below the broader US market benchmark suggest limited room for error on future returns.

If that risk feels a bit tight for comfort, stress test your portfolio by checking stocks in the 72 resilient stocks with low risk scores and see how a more resilient profile compares.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.